Trial intelligence / Profile preview

Topical naloxone for chronic pruritus induced by chemical injuries

IRCT201702221165N17Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Mar 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of naloxone in chronic pruritus (CP), sponsored by Baqiyatallah University of Medical Sciences. Started Mar 2017; status: completed.

02

Drugs

naloxone
03

Conditions

chronic pruritus (CP)

Beyond the preview

Go deeper on IRCT201702221165N17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201702221165N17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call